Worldwide Prevalence of Opioid Use Disorders, 2019-2029 - Quantify Patient Populations to Target the Development of Future Products, Pricing Strategies and Launch Plans
DUBLIN, Feb. 12, 2020 /PRNewswire/ -- The "Prevalence of Opioid Use Disorder in 23 Major Markets 2019-2029" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
As a result of the increased death toll largely in western parts of the world because of opioid misuse of prescription drugs such as fentanyl, heroin continues to be crisis which affects public health as well as social and economic welfare.
This report provides the current incidence for Bell's palsy across 24 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Ireland, Brazil, Turkey, Mexico, Denmark, Argentina, Australia, Sweden, Denmark, Norway, Finland, The Netherlands, Poland, Russia, India, Switzerland, Austria) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of opioid use disorder have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main symptoms and co-morbidities for the disease include:
-- Drowsiness
-- Inability to control opioid use
-- Uncontrollable cravings
-- Changes in sleep habits
-- Weight loss
-- Frequent flu-like symptoms
-- Lack of hygiene
-- Isolation from family and friends
-- New financial difficulties
-- Change in volume of tears/saliva that the individual may produce
Reason to buy:
-- Able to quantify patient populations in global opioid use market to
target the development of future products, pricing strategies and launch
plans.
-- Gain further insight into the incidence of the subdivided types of
opioid use and identify patient segments with high potential.
-- Delivery of more accurate information for clinical trials in study
sizing and realistic patient recruitment for various countries.
-- Provide a level of understanding on the impact from specific co-morbid
conditions associated with opioid use
-- Identify sub-populations within opioid use which require treatment.
-- Gain an understanding of the specific markets that have the largest
number of opioid use patients
Key Topics Covered
1. Introduction
2. Cause Of The Disease
3. Risk Factors & Prevention
4. Diagnosis Of The Disease
5. Variation By Geography/Ethnicity
6. Disease Prognosis & Clinical Course
7. Key Comorbid Conditions/Features Associated With The Disease
8. Methodology For Quantification Of Patient Numbers
9. Additional Data Available On Request
10. Top-Line Prevalence For Opioid Use Disorder
11. Features Of Substance Abuse In Patients
12. Opioid Use, Heroin Use And Prescription Use
13. Co-Morbidities Associated With Opioid Use Disorder
14. Abbreviations Used In The Report
15. Other Services & Solutions
16. Reports & Publications
17. Online Epidemiology Databases
18. Online Pharmaceutical Pricing Database
For more information about this report visit https://www.researchandmarkets.com/r/ezblwb
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
